SURVODUTIDE

★★★★☆

(4.5 / 5 Reviews)

SURVODUTIDE RESEARCH STUDIES ABOUT Dual agonist with GLP-1 and glucagon receptor activity. GLP-1 lowers food intake and improves glycemic control, while glucagon signaling may increase energy expenditure and reduce liver fat. FOR RESEARCH USE ONLY.